For the top 50 pharmaceutical companies, BenchSci is the only preclinical R&D SaaS platform that brings novel medicine to patients 50% faster with 80% fewer experiments. BenchSci achieves this by decoding the world's biomedical data with machine learning to increase experimental success, eliminate wasted work, and drive scientific discovery. Unlike other companies using AI for drug discovery, BenchSci doesn't compete with pharmaceutical companies but equips their scientists with a powerful platform of AI-enabled applications to develop drugs better, faster, and more cost-effectively themselves.